 |
|
Plasma Histamine During Cardiopulmonary Bypass in Man
THEODORE COOPER, M.D.;
MAX JELLINEK, Ph.D.;
VALLEE L. WILLMAN, M.D.;
JOHN F. SCHWEISS, M.D.;
C. ROLLINS HANLON, M.D.
AMA Arch Surg. 1963;86(1):138-142.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Many factors influence the adequacy and distribution of systemic blood flow during extracorporeal circulation.1 The liberation of endogenous vasoactive substances may alter the character of the perfusion or modify the function of various organs. Even during perfusions with conditions maintained within "physiologic" limits, there may be alterations in blood catecholamine levels.2
Another vasoactive amine which may be liberated from intracellular sites by a variety of interventions is histamine. This substance has many pharmacologic properties which might alter the status of an animal during cardiopulmonary bypass.3 It may increase vascular permeability, modify ganglionic transmission in the sympathetic nervous system, alter regional flow by relaxation of vascular smooth muscle, or affect the heart directly. In addition it may cause bronchiolar constriction; this could have a bearing on the pulmonary complications that may follow cardiopulmonary bypass.
Because of these relevant possibilities, it seemed desirable to study plasma histamine levels during
. . . [Full Text PDF of this Article]
Author Affiliations
ST. LOUIS
From the Department of Surgery and the Center for Cardiovascular Research, St. Louis University School of Medicine.
Footnotes
Read before the 10th Scientific Meeting of the International Cardiovascular Society, North American Chapter, Chicago, June 23, 1962.
Aided by American Heart Association Grant 60-G-78 and by Grants H-5819 and H-6312, USPHS.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
|
